ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,145, issued on Aug. 26, was assigned to THE BROAD INSTITUTE INC. (Cambridge, Mass.), The General Hospital Corp. (Boston) and DANA-FARBER CANCER INSTITUTE INC. (Boston).

"Bicyclic urea kinase inhibitors and uses thereof" was invented by Nathanael S. Gray (Stanford, Calif.), Yanke Liang (Belmont, Mass.), Hwan Geun Choi (Chestnut Hill, Mass.), Thomas Sundberg (Boston), Alykhan Shamji (Somerville, Mass.), Ramnik Xavier (Brookline, Mass.), David E. Fisher (Newton, Mass.) and Nisma Mujahid (Spencerport, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I), (II), and (III). The provided compounds are ...